Key Votes
HB 1001 - Expanding Bioscience Research Funding - Key Vote
Colorado Key Votes
Lois Tochtrop voted Yea (Passage With Amendment) on this legislation.
Read recent statements Lois Tochtrop made in this general time period.
Stages
- April 24, 2008 Executive Signed
- April 22, 2008 Senate Conference Report Adopted
- April 22, 2008 House Conference Report Adopted
- April 15, 2008 House Nonconcurrence Vote Passed
- April 8, 2008 Senate Bill Passed
- April 7, 2008 Senate Bill Passed
- Feb. 27, 2008 House Bill Passed
- Jan. 9, 2008 Introduced
Family
Issues
Stage Details
Legislation - Signed (Executive) - April 24, 2008
Title: Expanding Bioscience Research Funding
Signed by Governor Bill Ritter, Jr.
Legislation - Conference Report Adopted (Senate) (25-9) - April 22, 2008
Legislation - Conference Report Adopted (House) (53-10) - April 22, 2008
Legislation - Nonconcurrence Vote Passed (House) (60-3) - April 15, 2008
Legislation - Bill Passed (Senate) (26-9) - April 8, 2008 (Key vote)
Title: Expanding Bioscience Research Funding
Vote Smart's Synopsis:
Vote to pass a bill that expands state funding of bioscience research and allows early-stage bioscience companies to receive state government grants.
Highlights:
- Limits individual grants to $150,000 per early-stage bioscience research project, and limits the total amount of grant money an early-stage bioscience research company may receive to $250,000 (Sec. 1).
- Requires at least 30 percent of the Bioscience Discovery Evaluation Cash Fund be used to provide grants to offices of technology transfer for projects that focus on life sciences, engineering, material science, computer sciences, photonics, or nanotechnology (Sec. 1).
- Requires at least 30 percent of the Bioscience Discovery Evaluation Cash Fund be used to provide grants to early-stage bioscience companies that have licensed a technology from an in-state research institution or an office of technology transfer for the purpose of promoting the commercialization of therapeutic or diagnostic instruments to improve human health, bioscience technologies to improve agriculture, or biofuels (Sec. 1).
- Limits eligibility for early-stage bioscience research grants to companies that have received less than $25 million in funds from grants and third-party investors, employs fewer than 20 individuals, and has its headquarters located in Colorado (Sec. 1).
- Transfers $4.5 million from the Limited Gaming Fund to the Bioscience Discovery Evaluation Cash Fund for fiscal year 2008-2009, and $5.5 million for fiscal years 2009-2010, 2010-2011, and 2011-2012 (Sec. 2).
- Appropriates $5.5 million from the General Fund to the Bioscience Discovery Evaluation Cash Fund beginning in fiscal year 2008-2009 (Sec. 3).
Note:
NOTE: THIS VOTE RECONSIDERS A PREVIOUS VOTE.
Legislation - Bill Passed (Senate) (32-1) - April 7, 2008
Legislation - Bill Passed (House) (52-13) - Feb. 27, 2008 (Key vote)
Title: Expanding Bioscience Research Funding
Vote Smart's Synopsis:
Vote to pass a bill that expands state funding of bioscience research and allows early-stage bioscience companies to receive state government grants.
Highlights:
- Limits individual grants to $150,000 per early-stage bioscience research project, and limits the total amount of grant money an early-stage bioscience research company may receive to $250,000 (Sec. 1).
- Requires at least 30 percent of the Bioscience Discovery Evaluation Cash Fund be used to provide grants to offices of technology transfer for projects that focus on life sciences, engineering, material science, computer sciences, photonics, or nanotechnology (Sec. 1).
- Requires at least 30 percent of the Bioscience Discovery Evaluation Cash Fund be used to provide grants to early-stage bioscience companies that have licensed a technology from an in-state research institution for the purpose of promoting the commercialization of therapeutic or diagnostic instruments to improve human health, bioscience technologies to improve agriculture, or biofuels (Sec. 1).
- Limits eligibility for early-stage bioscience research grants to companies that have received less than $25 million in funds from grants and third-party investors, employs fewer than 20 individuals, and has its headquarters located in Colorado (Sec. 1).
- Transfers $4.5 million from the Limited Gaming Fund to the Bioscience Discovery Evaluation Cash Fund for fiscal year 2008-2009, and $5.5 million for fiscal years 2009-2010, 2010-2011, and 2011-2012 (Sec. 2).
- Appropriates $5.5 million from the General Fund to the Bioscience Discovery Evaluation Cash Fund beginning in fiscal year 2008-2009 (Sec. 3).
Legislation - Introduced (House) - Jan. 9, 2008
Title: Expanding Bioscience Research Funding
Sponsors
- Bob L. Bacon (CO - D) (Out Of Office)
- Cheri E. Jahn (CO - D) (Out Of Office)
- Dianne I. Primavera (CO - D) (Out Of Office)
- James L. 'Jim' Riesberg (CO - D) (Out Of Office)
- Chris Romer (CO - D) (Out Of Office)
- Brandon C. Shaffer (CO - D) (Out Of Office)
- Sue Windels (CO - D) (Out Of Office)
Co-sponsors
- Alice J. Borodkin (CO - D) (Out Of Office)
- Betty Boyd (CO - D) (Out Of Office)
- Bernie Buescher (CO - D) (Out Of Office)
- Dorothy B. Butcher (CO - D) (Out Of Office)
- Morgan L. Carroll (CO - D) (Out Of Office)
- Edward Casso (CO - D) (Out Of Office)
- Mark Ferrandino (CO - D)
- Randy Fischer (CO - D)
- K. Jerry Frangas (CO - D) (Out Of Office)
- Dan Gibbs (CO - D) (Out Of Office)
- Kenneth Marshall 'Ken' Gordon (CO - D) (Out Of Office)
- Peter C. Groff (CO - D) (Out Of Office)
- Mary A. Hodge (CO - D) (Out Of Office)
- James 'Jim' Isgar (CO - D) (Out Of Office)
- Steve Johnson (CO - R) (Out Of Office)
- John M. Kefalas (CO - D) (Out Of Office)
- Andrew 'Andy' Kerr (CO - D) (Out Of Office)
- James E. 'Jim' Kerr (CO - R) (Out Of Office)
- Mike Kopp (CO - R) (Out Of Office)
- Alice D. Madden (CO - D) (Out Of Office)
- Don Marostica (CO - R) (Out Of Office)
- Thomas W. 'Tom' Massey Jr. (CO - R) (Out Of Office)
- Liane 'Buffie' McFadyen (CO - D) (Out Of Office)
- Karen Middleton (CO - D) (Out Of Office)
- John P. Morse (CO - D)
- Cherylin N. Peniston (CO - D)
- Joe Rice (CO - D) (Out Of Office)
- Andrew Romanoff (CO - D) (Out Of Office)
- Raymond J. 'Ray' Rose (CO - R) (Out Of Office)
- Christine Scanlan (CO - D) (Out Of Office)
- Gail S. Schwartz (CO - D)
- Susan K. Shepherd (CO - D) (Out Of Office)
- Nancy Spence (CO - R) (Out Of Office)
- Abel J. Tapia (CO - D) (Out Of Office)
- Lois A. Tochtrop (CO - D)
- Nancy Janann Todd (CO - D) (Out Of Office)
- Ron D. Tupa (CO - D) (Out Of Office)
- Albert C. 'Al' White (CO - R) (Out Of Office)
- Suzanne S. Williams (CO - D) (Out Of Office)
- John P. Witwer (CO - R) (Out Of Office)
